Prescription drug · ANDA
Pryidostigmine Bromide (pyridostigmine bromide) NDC 24689-104
Pyridostigmine bromide 60 mg/5mL · Solution · Oral · Apnar Pharma LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24689-104-01 | 24689010401 | 473 mL in 1 BOTTLE, PLASTIC (24689-104-01)Marketed from Jun 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pryidostigmine Bromide
- Generic name (nonproprietary)
- pyridostigmine bromide
- Active ingredients
- Pyridostigmine bromide — 60 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Apnar Pharma LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208797
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 24689-104_2b49cf3c-cbbf-9429-e063-6294a90a0166SPL ID 2b49cf3c-cbbf-9429-e063-6294a90a0166SPL set ID d42f2d2e-b9f8-7c22-e053-2995a90a9661RxCUI 903843UNII KVI301NA53UPC 0324689104010
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424689010401followed by a unit qualifier and the quantityPackage 24689-0104-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATION Pyridostigmine bromide oral solution USP is useful in the treatment of myasthenia gravis.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 208797
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pryidostigmine Bromidepyridostigmine bromide | Pyridostigmine bromide 60 mg/5mL | SolutionOral | Rising Pharma Holdings, Inc. | 16571-833 |